Biodexa Pharmaceuticals (BDRX) Interest & Investment Income (2016 - 2024)

Biodexa Pharmaceuticals (BDRX) has 5 years of Interest & Investment Income data on file, last reported at $1.1 million in Q4 2024.

• For the quarter ending Q4 2024, Interest & Investment Income changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2024 stood at $2.7 million (changed N/A YoY), and the FY2025 full-year result was $3.1 million, down 27.62% from the prior year.
• Interest & Investment Income grew to $1.1 million in Q4 2024, from $473863.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q4 2024 to a low of $473863.0 in Q4 2022.
• A 3-year average of $672172.4 and a median of $639714.4 in 2020 frame the typical range for Interest & Investment Income.
• Peak annual rise in Interest & Investment Income reached 52072.06% in 2020, while the deepest fall reached 52072.06% in 2020.
• Tracing BDRX's Interest & Investment Income over 3 years: stood at $670789.1 in 2020, then fell by 29.36% to $473863.0 in 2022, then surged by 127.25% to $1.1 million in 2024.
• Business Quant data shows BDRX's Interest & Investment Income at $1.1 million in Q4 2024, $473863.0 in Q4 2022, and $499637.3 in Q3 2022.